UBS Group’s Putnam BioRevolution ETF SYNB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $368 | Hold |
13
| – | – | ﹤0.01% | 8520 |
|
|
2025
Q1 | $364 | Buy |
13
+2
| +18% | +$56 | ﹤0.01% | 8489 |
|
|
2024
Q4 | $325 | Hold |
11
| – | – | ﹤0.01% | 8270 |
|
|
2024
Q3 | $364 | Sell |
11
-1
| -8% | -$33 | ﹤0.01% | 7758 |
|
|
2024
Q2 | $374 | Hold |
12
| – | – | ﹤0.01% | 7784 |
|
|
2024
Q1 | $372 | Sell |
12
-100
| -89% | -$3.1K | ﹤0.01% | 7427 |
|
|
2023
Q4 | $3.26K | Buy |
+112
| New | +$3.26K | ﹤0.01% | 6784 |
|
|
2023
Q1 | – | Sell |
-258
| Closed | -$6.7K | – | 9002 |
|
|
2022
Q4 | $6.7K | Buy |
+258
| New | +$6.7K | ﹤0.01% | 7802 |
|